Table 5.
Factors associated with VAP based on univariate and multivariable logistic regression model.
| Variables | Crude ORa, 95% CI | p-value | Adjusted OR, 95% CI | p-value |
|---|---|---|---|---|
| Age (≤1 year) | Reference | 0.289 | Reference | 0.454 |
| Age (>1 year) | 0.57 (0.21–1.58) | 0.65 (0.21–2.006) | ||
| Gender/Male | Reference | 0.105 | Reference | 0.205 |
| Gender/Female | 0.42 (0.14–1.20) | 0.47 (0.14–1.50) | ||
| PIM3 | 1.02 (0.91–1.15) | 0.647 | 0.97 (0.85–1.11) | 0.733 |
| Group | ||||
| Placebo | Reference | 0.039* | Reference | 0.041* |
| Intervention | 0.33 (0.12–0.94) | 0.29 (0.09–0.95) | ||
| ICU stays (days) | 1.03 (0.99–1.08) | 0.115 | 1.04 (0.96–1.12) | 0.277 |
| Ventilation time (h) | 1.001 (0.99–1.004) | 0.272 | 0.99 (0.99–1.004) | 0.874 |
| Vasopressor administration/No | Reference | 0.055 | Reference | 0.091 |
| Vasopressor administration/ Yes | 2.80 (0.98–8.02) | 2.72 (0.85–8.68) | ||
ICU, intensive care unit; PIM3, pediatric index of mortality 3.
*
Statistically significant, p-value <0.05.
a
Odds ratio, 95% confidence interval.